Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson’s disease - network meta-analysis

Abstract It remains unclear which adjunctive drug for Parkinson’s disease (PD) in combination with levodopa is more effective, tolerable, and safe. We aimed to compare the efficacy, tolerability, and safety among anti-PD drugs from several classes in patients with fluctuating PD who received levodop...

Full description

Bibliographic Details
Main Authors: Wataru Sako, Yuki Kogo, Michinori Koebis, Yoshiaki Kita, Hajime Yamakage, Takayuki Ishida, Nobutaka Hattori
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-023-00589-8